About this trial
The purpose of this study is to evaluate an alternative way of continuously measuring blood pressure in patients coming for complex surgery. The investigators will directly compare the speed of set up and accuracy of the new ClearSight monitor to those taken by the arterial line monitor, which is the current gold standard for recording blood pressure measurements.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
written informed consent
undergoing elective cardiac surgery OR elective neurointerventional surgery (with standard arterial radial line for continuous blood pressure monitoring)
Disqualifiers
undergoing emergent cardiac surgery OR emergent neurointerventional surgery
Trial population
These participants are receiving either elective cardiac surgery or elective neurointerventional surgery at the Royal University Hospital, Saskatoon.
Trial design
Cohort
Prospective
Treatments tested in this trial
ClearSight System
DevicePatients having either elective cardiac surgery or elective neurointerventional surgery will have blood pressure monitored by the ClearSight device, along with the standard of care radial arterial line, throughout their surgery. The arterial line will be placed on the radial artery contralateral to the upper arm blood pressure cuff. The ClearSight device will then be placed on the third finger of the hand ipsilateral to the radial arterial line.
Treatment groups
Trial outcomes
Primary outcomes
systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP)
compare differences in blood pressure parameters (SBP, DBP, MAP) collected by ClearSight system versus gold standard (radial arterial line)
Secondary outcomes
time to place instrument
compare time to place the radial arterial line, and ClearSight finger cuff and wrist strap
Sponsors and contacts
Click on the lead sponsor to view all of their trials.